Home » Patent watch: Hopkins, Arrow win infringement case involving ProLumen device
Patent watch: Hopkins, Arrow win infringement case involving ProLumen device
A Medical Device Daily
The Johns Hopkins University (Baltimore) and Arrow International (Reading, Pennsylvania) reported winning a patent infringement suit against Datascope (Montvale, New Jersey) in the U.S. District Court in Baltimore.
Hopkins and Arrow had brought suit against Datascope charging infringement of patents relating to the Arrow-Trerotola Percutaneous Thrombolytic Device (PTD), used by interventionalists for treating hemodialysis patients.
The jury ruled that the Datascope ProLumen device infringed three patents owned by Hopkins and licensed by Arrow, and upheld their validity. The jury also awarded damages amounting to an 18% royalty on Datascope's sales of the infringing device.
Hopkins and Arrow have asked the court to issue a permanent injunction against Datascope's sales of the ProLumen.
Dr. Scott Trerotola, now with the University of Pennsylvania (Philadelphia), in the early 1990s invented the PTD, used to clean clotted dialysis grafts, while working at Hopkins. Arrow, having an exclusive license for the technology, recently celebrated the 10-year anniversary of device development, saying that tens of thousands of patients have been treated with the device.
Hopkins and Arrow were represented by attorneys with Amster, Rothstein & Ebenstein (New York), an intellectual property law firm.
Arrow develops disposable catheters and related products for critical and cardiac care.
In other patent news:Cleveland Clinic (Cleveland, Ohio) reported receiving four U.S. patents for innovations in the detection of cardiovascular disease, vascular imaging, deep brain stimulation and blood circulation.
Patent No. 7,223,552 was received for new diagnostic tests for characterizing an individual's risk of developing or having a cardiovascular disease. The tests were developed by Stanley Hazen, MD, PhD, and Renliang Zhang, MD, PhD.
Patent No. 7,215,802 was issued for a new system and method which uses radio waves to identify borders of vascular tissue — developed by Jon Klingensmith, Anuja Nair, PhD, Barry Kuban and Geoffrey Vince, PhD.
Patent No. 7,181,288 was issued for a lead used in deep brain stimulation and the method for using it — developed by Ali Rezai, MD, Kuban, Ken Baker and John Hall.
Patent No. 7,189,260 was issued for a centrifugal flow blood pump usable in heart surgery — developed by David Horvath, Leonard Golding, MD, and William Smith.
CCF Innovations , the technology commercialization arm of Cleveland Clinic, oversees the clinic's technology strategy.